Roxanne Lagano - Feb 8, 2022 Form 4 Insider Report for Zoetis Inc. (ZTS)

Role
Executive Vice President
Signature
/s/ Brenda Santuccio, as Attorney-in-Fact
Stock symbol
ZTS
Transactions as of
Feb 8, 2022
Transactions value $
$0
Form type
4
Date filed
2/10/2022, 05:37 PM
Previous filing
Jan 19, 2022
Next filing
Feb 15, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZTS Performance Award Unit Award $0 +10.5K $0.00 10.5K Feb 8, 2022 Common Stock 10.5K Direct F1, F2, F3, F4
transaction ZTS Restricted Stock Unit Award $0 +1.37K +20.78% $0.00 7.94K Feb 8, 2022 Common Stock 1.37K Direct F4, F5, F6, F7, F8
transaction ZTS Stock Option Award $0 +5.38K +13.16% $0.00 46.2K Feb 8, 2022 Common Stock 5.38K Direct F9, F10, F11, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance award units with a three-year performance period covering 2019-2021 that were granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon. The performance award units reported herein were deemed acquired on February 8, 2022, which is the date the Zoetis Human Resources Committee certified the level of achievement of the applicable performance goal for these performance award units. The performance award units (and dividend equivalent units issued thereon) will vest and be settled in shares of Zoetis common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F2 Each performance award unit represents a contingent right to receive one share of Zoetis Inc. common stock.
F3 Each performance award unit will vest and be settled in shares of Zoetis Inc. common stock on February 12, 2022, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F4 Not applicable.
F5 Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs"). Restricted stock units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. Dividend equivalent units vest and are settled in shares of Zoetis common stock on the third anniversary of the date of grant of the underlying restricted stock units, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F6 Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
F7 Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
F8 The RSUs vest as follows: 3,050.4942 RSUs will vest on February 12, 2022; 1,842.4714 RSUs will vest on February 11, 2023; 1,682.2157 RSUs will vest on February 10, 2024; and 1,366 RSUs will vest on February 8, 2025.
F9 Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
F10 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; 12,052 options granted February 12, 2019 at an exercise price of $87.51 per option; 7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
F11 Each option vests on the third anniversary of the date of grant.
F12 Each option expires on the tenth anniversary of the date of grant.